Oxford Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $597K | Buy |
|
|||||
|
2025
Q1 | $152K | Buy |
|
|||||
|
2024
Q4 | $99K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $747K | Sell |
|
|||||
|
2018
Q2 | $1.17M | Sell |
|
|||||
|
2018
Q1 | $1.58M | Buy |
|
|||||
|
2017
Q4 | $1.21M | Buy |
|
|||||
|
2017
Q3 | $61K | Sell |
|
|||||
|
2017
Q2 | $660K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $110K | Sell |
|
|||||
|
2015
Q3 | $2.66M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $2.07M | Sell |
|
|||||
|
2014
Q2 | $3.73M | Buy |
|